Annexin Pharmaceuticals AB (publ) (STO: ANNX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.460
-0.010 (-2.13%)
Nov 19, 2024, 4:33 PM CET
27.60%
Market Cap 254.76M
Revenue (ttm) n/a
Net Income (ttm) -52.45M
Shares Out 532.98M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 94,607
Open 0.445
Previous Close 0.470
Day's Range 0.440 - 0.481
52-Week Range 0.203 - 0.932
Beta 1.09
Analysts n/a
Price Target n/a
Earnings Date Feb 7, 2025

About ANNX

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol ANNX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.